TD Waterhouse Canada’s Sunshine Biopharma SBFM Stock Holding History

TD Waterhouse Canada’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Buy	+1	New	+$6	﹤0.01%	2396
2026 Q1	–	Hold	0	–	–	–	2305
2025 Q4	–	Hold	0	–	–	–	2038
2025 Q3	–	Hold	0	–	–	–	2062
2025 Q2	–	Hold	0	–	–	–	1990
2025 Q1	–	Hold	0	–	–	–	1946
2024 Q4	–	Hold	0	–	–	–	1960
2024 Q3	–	Hold	0	–	–	–	1902

Other funds holding SBFM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SFG

Strive Financial Group Carmel, Indiana $230M AUM

TD Waterhouse Canada's SBFM Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Sunshine Biopharma (SBFM) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #2396 among its holdings.

9 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

TD Waterhouse Canada held 1 share of Sunshine Biopharma worth $2 as of Q2 2026.
Sunshine Biopharma was a new TD Waterhouse Canada position in Q2 2026.
Sunshine Biopharma made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2396 holding.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.